Monitoring and clinical oversight to shift delivery of high-cost, high-touch therapies such as CAR-T and bispecifics, and other complex therapies safe to deliver in ambulatory settings.
(Internal)
(Rajeeve 2025)
(Rajeeve 2026)
(Internal)
Current Health provides clinical oversight and passive vital sign monitioring, detecting adverse events while moving with the patient, supporting post-infusion observation while improving throughput. Deliver high-cost and complex therapies at the optimal site—HOPD or ambulatory infusion suite—with full coverage outside the infusion chair.
(Internal).
When a step-up dose or infusion requires observation, the historical answer has been admission. Current Health gives your program the infrastructure to safely administer and observe those therapies outpatient.
Our FDA-cleared passive monitoring detects emerging toxicities such as CRS and other adverse events, often before the patient notices symptoms, so your team can intervene from the clinic rather than an unplanned admission.
Configurable symptom surveys, on-demand video calls, and our Clinical Command Center team assess and escalate to the overseeing provider under your pre-defined protocols, giving you the peace of mind an inpatient stay used to provide.
If your organization runs home infusion, the Clinical Command Center can coordinate in-home labs and assessments, so diagnosing and managing an adverse event does not require a clinic or ED visit.
(Internal).
(Internal).
